DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 5 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $474,000 | +42.8% | 32,100 | +24.7% | 0.00% | – |
Q2 2023 | $332,000 | +83.4% | 25,751 | +40.3% | 0.00% | – |
Q1 2023 | $181,000 | -45.0% | 18,359 | -40.4% | 0.00% | – |
Q4 2022 | $329,000 | +104.3% | 30,815 | +99.2% | 0.00% | – |
Q3 2022 | $161,000 | -59.8% | 15,471 | -51.4% | 0.00% | – |
Q2 2022 | $400,000 | -2.0% | 31,824 | -15.3% | 0.00% | – |
Q1 2022 | $408,000 | -26.4% | 37,556 | -4.6% | 0.00% | – |
Q4 2021 | $554,000 | -19.9% | 39,357 | +9.2% | 0.00% | – |
Q3 2021 | $692,000 | +284.4% | 36,027 | +97.4% | 0.00% | – |
Q2 2021 | $180,000 | +2.9% | 18,252 | +2.2% | 0.00% | – |
Q1 2021 | $175,000 | +121.5% | 17,851 | +1.4% | 0.00% | – |
Q4 2020 | $79,000 | -49.7% | 17,610 | -51.7% | 0.00% | – |
Q3 2020 | $157,000 | -50.0% | 36,445 | +2.9% | 0.00% | – |
Q2 2020 | $314,000 | -31.0% | 35,402 | -72.6% | 0.00% | – |
Q1 2020 | $455,000 | -33.6% | 128,971 | +7.7% | 0.00% | – |
Q4 2019 | $685,000 | +146.4% | 119,697 | +53.9% | 0.00% | – |
Q3 2019 | $278,000 | +561.9% | 77,777 | +640.6% | 0.00% | – |
Q2 2019 | $42,000 | -69.3% | 10,502 | -44.1% | 0.00% | – |
Q1 2019 | $137,000 | -18.5% | 18,771 | +2.8% | 0.00% | – |
Q4 2018 | $168,000 | -25.0% | 18,268 | +1.6% | 0.00% | – |
Q3 2018 | $224,000 | -15.5% | 17,987 | +3.5% | 0.00% | – |
Q2 2018 | $265,000 | -25.4% | 17,386 | -2.7% | 0.00% | – |
Q1 2018 | $355,000 | +1.4% | 17,876 | -4.5% | 0.00% | – |
Q4 2017 | $350,000 | -31.4% | 18,728 | -20.9% | 0.00% | – |
Q3 2017 | $510,000 | +157.6% | 23,677 | +15.8% | 0.00% | – |
Q2 2017 | $198,000 | +90.4% | 20,454 | +17.0% | 0.00% | – |
Q1 2017 | $104,000 | +42.5% | 17,479 | -5.9% | 0.00% | – |
Q4 2016 | $73,000 | -64.2% | 18,570 | -4.6% | 0.00% | – |
Q3 2016 | $204,000 | -28.2% | 19,471 | 0.0% | 0.00% | – |
Q2 2016 | $284,000 | -22.6% | 19,471 | +1.9% | 0.00% | – |
Q1 2016 | $367,000 | -77.3% | 19,108 | -71.4% | 0.00% | -100.0% |
Q4 2015 | $1,616,000 | +631.2% | 66,892 | +644.0% | 0.00% | – |
Q3 2015 | $221,000 | +1909.1% | 8,991 | +1813.0% | 0.00% | – |
Q2 2015 | $11,000 | -8.3% | 470 | -17.5% | 0.00% | – |
Q1 2015 | $12,000 | +50.0% | 570 | +21.3% | 0.00% | – |
Q4 2014 | $8,000 | – | 470 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |